Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MDXG · against 452 other Healthcare companies of similar size
Ranked #187 of 453 · scores higher than 59% of peers · safety percentile 63
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)59 peers with a safety percentile of 60–69, including MDXG · Click a bar to see the companies
A mix: stronger current ratio and debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | MDXG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 421 reported | 0.08× | 0.18× | 64% | 33% | |
| BetaLower is better · 434 reported | 1.17 | 0.43 | 17% | 33% | |
| Current ratioHigher is better · 446 reported | 5.33× | 2.88× | 71% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 421M USD | 99 | 52 | |
| 2 | 261M USD | 99 | 97 | |
| 3 | 397M USD | 99 | 37 | |
| 4 | 455M USD | 99 | 53 | |
| 5 | 2.7B CNY (≈$375M) | 99 | 67 | |
| 183 | 394M USD | 64 | 37 | |
| 184 | 374M USD | 64 | 66 | |
| 185 | 55.7B JPY (≈$379M) | 64 | 64 | |
| 186 | 4.6B CNY (≈$639M) | 64 | 68 | |
| 187 | 474M USD | 63 | 46 | |
| 188 | 862M AUD (≈$569M) | 63 | 54 | |
| 189 | 73.8B JPY (≈$502M) | 63 | 62 | |
| 190 | 319M USD | 63 | 28 | |
| 191 | 1.1B CAD (≈$807M) | 63 | 60 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score